The STEP 4Life Trial

Completed · Not applicable

Conditions studied: Alzheimer Disease, At Risk, Alzheimer Disease, Protection Against, Dementia

In brief

The objective of this study is to test the feasibility of using behavioral economic interventions (gamification with social incentives) targeting daily step counts to prevent or delay the development of Alzheimer's Disease and Related Dementias (ADRD).

Key facts

Study ID

NCT05069155

Run by

University of Pennsylvania

People needed

240

Starts

2021-11-01

Expected to finish

2023-01-02

Last updated by the study team

2023-11-28

Who can join

Age: 55 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• own a smartphone
• be enrolled in GeneMatch
• know their genetic testing results (APOE4)
• able to provide informed consent

You may not qualify if…

• Inability to provide informed consent
• does not have daily access to a smartphone compatible with the wearable device and not willing to use a device that we can provide them
• already enrolled in another physical activity study
• unable to ambulate independently
• any other medical conditions that would prohibit participation in physical activity program

Where it is running

• Blockley Hall — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.